David A. Socks, Director at Phathom Pharmaceuticals, Inc. (PHAT), sold 78,600 shares at $35.69 ($2.9M) on 2021-04-05, disclosed to the SEC on 2021-04-07.
Open-market sale of $2.9M PHAT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.69 | 12,619 | $450K | 15.7% |
| 2 | $35.69 | 12,619 | $450K | 15.7% |
| 3 | $36.40 | 7,769 | $283K | 9.8% |
| 4 | $36.40 | 7,769 | $283K | 9.8% |
| 5 | $37.15 | 1,730 | $64K | 2.2% |
| 6 | $37.15 | 1,730 |
| $64K |
| 2.2% |
| 7 | $34.96 | 1,400 | $49K | 1.7% |
| 8 | $35.97 | 3,359 | $121K | 4.2% |
| 9 | $35.97 | 3,359 | $121K | 4.2% |
| 10 | $37.37 | 6,328 | $236K | 8.2% |
| 11 | $37.37 | 6,328 | $236K | 8.2% |
| 12 | $38.03 | 6,795 | $258K | 9.0% |
| 13 | $38.03 | 6,795 | $258K | 9.0% |
| Total | $36.58 avg | 78,600 | $2.9M | 100% |
| Filing → |
| PHAT | SELL | 2021-08-18 | $1.1M | — | Filing → |
| PHAT | SELL | 2021-06-29 | $2.2M | — | Filing → |
| PHAT | SELL | 2021-05-21 | $2.6M | — | Filing → |